Merck Breaks Ground on $1 Billion Biologics Center in Wilmington, Delaware
On Apr. 29, 2025, Merck announced the start of construction for a $1 billion, 470,000 square-foot state-of-the-art biologics…
Merck to Acquire SpringWorks Therapeutics for $3.9 Billion
On Apr. 28, 2025, Merck and SpringWorks Therapeutics announced the companies have entered into a definitive agreement for…
Roche to invest $50 billion in pharmaceuticals and diagnostics in the U.S. over the next five years
On Apr. 22, 2025, Roche announced that it will invest USD $50 billion into the United States in…
Agriculture | Biotechnology | COVID-19 | Diagnostics | Energy | Environmental | EPA | FDA | Forestry | Genomics | HIV | Infectious Disease | Influenza | Life Science News | Measles | Nanotechnology | Neurology | NIH | Oncology | Pharmaceutical | Polio | Stem Cell | Therapeutics | USDA | Vaccine | Veterinary | Women's Health
Cartoon Illustrating “The NIH and U.S. Healthcare in Crisis” Published
On Apr. 21, 2025, LifeScienceHistory.com published the cartoon: “The National Institutes of Health (NIH) and U.S. Healthcare in…
Novartis to expand US-based manufacturing and R&D footprint with investment of $23B over the next 5 years
On Apr. 10, 2025, Novartis, a leading global innovative medicines company, announced a planned $23 billion investment over…
Biotechnology | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease | Influenza | Life Science News | Measles | Medicine | Neurology | NIH | Oncology | Organ Transplant | Pharmaceutical | Plague | Polio | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
HHS starts layoffs of thousands of workers across its agencies
On Apr. 1, 2025, layoff notices began arriving for thousands of employees of the sprawling U.S. Department of…
Merck buys rights to heart disease drug in latest China deal worth up to $2 billion
On Mar. 25, 2025, Merck announced it has signed a licensing agreement for a heart disease drug with…
Bankruptcy judge approved federal settlement with Purdue Pharma
On Mar. 20, 2025, Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan, a major step towards finalizing a…
Mallinckrodt and Endo Combine in $6.7 billion Deal to Create Diversified Pharmaceuticals Leader
Mar. 13, 2025, Mallinckrodt and Endo,announced that they had entered into a definitive agreement to combine in a stock…
Biotechnology | Genomics | Infectious Disease | Life Science News | Medicine | Nanotechnology | Pharmaceutical | Vaccine
“Earth is a Rock, Let the DNA Mold me” rewritten hit Rock n’ Roll Song Celebrating ‘Science and Reason’ released
On Mar. 3, 2025, LifeScienceHistory.com: Where history is made daily announces the release of a rewritten hit rock…
Biotechnology | Diagnostics | Disease | Infectious Disease | Life Science News | Pharmaceutical | Therapeutics
Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion
In Feb. 26, 2025, Eli Lilly announced that it plans to bolster its domestic medicine production across therapeutic…
Agriculture | Biotechnology | Infectious Disease | Influenza | Life Science News | Measles | Pharmaceutical | Polio | Therapeutics | Vaccine | Veterinary | WHO | Women's Health
U.S. announces withdrawal from the World Health Organization
On Jan. 20, 2025, the White House announced the United States will exit the World Health Organization (WHO)….
Chemical | FDA | Life Science News | Materials | Oncology | Pharmaceutical | U.S. Congress
U.S. FDA Revokes Authorization for the Use of Red No. 3 in Food and Ingested Drugs
On Jan. 15, 2025, the U.S. Food and Drug Administration (FDA) announced revoking the authorization for the use…
Biotechnology | Diagnostics | FDA | Life Science News | Medical Device | Medicine | Pharmaceutical | Rare Disease | Therapeutics
U.S. Food and Drug Administration approved 50 new therapeutics in 2024
On Jan. 14, 2025, the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) announced…
Biotechnology | Diagnostics | Environmental | Infectious Disease | Life Science News | Pharmaceutical
Scientists collect ‘microbial fingerprints’ found in household plumbing
On Dec. 10, 2024, a research team led by Fangqiong Ling, an assistant professor at Washington University in…
Drug Supply Chain Issues More Likely to Result in Shortages in U.S. Than Canada
On Oct. 31, 2024, researchers from the University of Pittsburgh reported results of a study that showed drug-related…
Biotechnology | Chemical | Diagnostics | Disease | Environmental | Life Science News | Nanotechnology | Pharmaceutical | Therapeutics
Nanoplastics can reduce the effectiveness of antibiotics
On Oct. 30, 2024, an international research team led by the University of Bonn reported results of a…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Non-Profit Research | Pharmaceutical | Therapeutics
Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies
On Oct. 16, 2024, Sanofi announced it will contribute $18 million to three Historically Black Medical Schools to…
Lundbeck to acquire Longboard Pharmaceuticals for $2.6 billion
On Oct. 14, 2024, Lundbeck and Longboard Pharmaceuticals announced an agreement for Lundbeck to acquire Longboard for payment…
U.S. FDA Approved Pfizer’s HYMPAVZI™ (marstacimab-hncq) for Treatment of Adults and Adolescents with Hemophilia A or B
On Oct. 11, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved HYMPAVZI™ (marstacimab-hncq)…
Lilly announced $4.5 billion investment in the Lilly Medicine Foundry – to drive innovation in drug production and medicines for clinical trials
On Oct. 2, 2024, Eli Lilly and Company announced a $4.5 billion investment to create the Lilly Medicine…
Biotechnology | Diagnostics | Life Science News | Oncology | Pharmaceutical | Radiology | Therapeutics | Women's Health
Breast Cancer Mortality Continues Three Decade Decline, but Steeper Increases in Incidence for Women <50
On Oct. 1, 2024, the American Cancer Society (ACS) released Breast Cancer Statistics, 2024, the organization’s biennial update…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Pharmaceutical | Therapeutics
Large-Scale Study Seeks to Unearth Causes of Persistent Symptoms of Lyme Disease
On Sept. 17, 2024, researchers from Tufts University announced they had received a $20.7 million grant from the…
Biotechnology | COVID-19 | Life Science News | Medical Device | Medicine | Pharmaceutical | Therapeutics | Vaccine
Covid-19 pandemic changed scientific publishing
On Sep. 9, 2024, Santo Fortunato, a professor at Luddy School of Informatics, reported that an international research…
Biotechnology | Disease | Life Science News | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
Emergent BioSolutions’ ACAM2000® Received U.S. FDA Approval for Mpox Indication
On Aug. 29, 2024, Emergent BioSolutions announced that the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
Lilly opened state-of-the-art research and development center in the Boston Seaport
On Aug. 13, 2024, Eli Lilly announced the opening of the Lilly Seaport Innovation Center (LSC), a research…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Pharmaceutical | Polio | Vaccine
Novartis, Viatris face lawsuit over ‘HeLa’ cell misuse claims
On Aug. 5, 2024, Novartis and Viatris were named a federal lawsuit in Maryland by the family of…
Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
On Jul. 3, 2024, Regeneron Pharmaceuticals and Sanofi announced that the European Commission (EC) has approved Dupixent® (dupilumab)…
Biotechnology | Disease | Life Science News | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
Emergent BioSolutions Awarded $250+ Million in Contract to Supply U.S. Government with Four Critical Medical Countermeasure Products
On Jul. 2, 2024, Emergent BioSolutions announced it had received more than $250 millionin contract modifications from the…
Novo Nordisk announced 4.1 billion USD investment to expand US manufacturing capacity
On Jun. 24, 2024, Novo Nordisk announced plans to invest 4.1 billion US dollars to build a second…